Physician profile
James Moran
NPI 1578093647
$435.26
in general payments reported to CMS, 2019-2025
11 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.30 · 2020: $40.13 · 2021: $30.36 · 2022: $17.00 · 2023: $113 · 2024: $91.37 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $316.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $140.35 | 2022-2025 | Euflexxa |
| Bioventus LLC | $60.53 | 2024-2025 | Durolane |
| Pacira Therapeutics, INC. | $57.39 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $38.25 | 2023 | Seglentis |
| Abiomed | $30.36 | 2021 | |
| Depuy Synthes Sales INC. | $24.21 | 2025 | Truespan Orthocord, Dynacord, Healix Knotless Peek |
| Sanofi-Aventis U.S. LLC | $18.71 | 2023 | |
| Djo, LLC | $18.46 | 2023 | Donjoy, Aircast |
| Axogen | $17.13 | 2025 | |
| Amgen INC. | $15.83 | 2024 | Krystexxa |
| Lilly USA, LLC | $14.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Moran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.